REFERENCES
- MMWR. Update: Blood Lead Levels–United States, 1991–1994. MMWR 1997; 46: 141–145
- Lanphear B., Dietrich K. N., Auinger P., Cox C. Cognitive Deficits Associated with Blood Lead Concentrations < 10 μg/dL in US Children and Adolescents. Public Health Reports 2000; 115: 521–529
- American Academy of Pediatrics Committee on Drugs. Treatment Guidelines for Lead Exposure in Children. Pediatrics 1995; 96: 155–160
- Centers for Disease Control, Service UDoHaH, Service PH. Preventing Lead Poisoning in Young Children. US Dept of Health and Human Services 1991
- Rosen J. F., Chesney R. W., Hamstra A., DeLuca H., Mahaffey K. R. Reduction in 1,25-Dihydroxyvitamin D in Children with Increased Lead Absorption. N. Engl. J. Med. 1980; 302: 1128–1130
- Graziano J. H., Lolacono N. J., Moulton T., Mitchell M. E., Slavkovick V., Zarate C. Controlled Study of Meso-2,3-Dimercaptosuccininc Acid for the Management of Childhood Lead Intoxication. J. Pediatr. 1992; 120: 133–139
- Graziano J. H., Lolacono N. J., Meyer P. Dose-Response Study of Oral 2,3-Dimercaptosuccinic Acid in Children with Elevated Blood Lead Concentrations. J. Pediatr. 1988; 113: 751–757
- Rogan W. J., Dietrich K. N., Ware J. H., Dockery D. W., Salganik M., Radcliffe J., Jones R. L., Ragan N. B., Chisolm J. J., Rhoads G. G. The Effect of Chelation Therapy with Succimer on Neuropsychological Development in Children Exposed to Lead. N. Engl. J. Med. 2001; 344(19)1421–1426
- Liebelt E. L., Shannon M. W. Oral Chelators for Childhood Lead Poisoning. Ped. Ann. 1994; 23: 616–626
- Marcus S. M. Experience with d-Penicillaine in Treating Lead Poisoning. Vet. Hum. Toxicol. 1982; 24: 18–20
- Shannon M., Graef J., Lovejoy F. H. Efficacy and Toxicity of d-Penicillamine in Low-Level Lead Poisoning. J. Pediatr. 1988; 112: 799–804
- Shannon M., Grace A., Graef J. W. Use of Penicillamine in Children with Small Lead Burdens. N. Engl. J. Med. 1989; 321: 979–980
- Shannon M. W., Townsend M. K. Efficacy of Reduced-Dose d-Penicillamine in Children with Mild to Moderate Lead Poisoning. Ann. Pharmacotherapy 2000; 34: 15–18